Page last updated: 2024-08-21

malondialdehyde and dimethylaminomicheliolide

malondialdehyde has been researched along with dimethylaminomicheliolide in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Che, Y; Feng, X; Guo, X; He, Q; Huang, Z; Liu, Q; Peng, Z; Zhang, S; Zhu, D1

Other Studies

1 other study(ies) available for malondialdehyde and dimethylaminomicheliolide

ArticleYear
Anti-neuroinflammatory effects of dimethylaminomylide (DMAMCL, i.e., ACT001) are associated with attenuating the NLRP3 inflammasome in MPTP-induced Parkinson disease in mice.
    Behavioural brain research, 2020, 04-06, Volume: 383

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Catalase; Circadian Rhythm; Corpus Striatum; Cytokines; Dopaminergic Neurons; Inflammasomes; Inflammation; Malondialdehyde; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress; Parkinsonian Disorders; Sesquiterpenes, Guaiane; Substantia Nigra; Superoxide Dismutase; Tyrosine 3-Monooxygenase

2020